about
Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposurePathogenesis of acute kidney injury: foundation for clinical practice.Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells.Pathophysiology of cisplatin-induced acute kidney injury.Tubular p53 regulates multiple genes to mediate AKITaurine and the renal systemStress-responsive gene TauT and acute kidney injury.Knockout of the TauT gene predisposes C57BL/6 mice to streptozotocin-induced diabetic nephropathy.Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.miR-3156-3p is downregulated in HPV-positive cervical cancer and performs as a tumor-suppressive miRNA.Klotho has dual protective effects on cisplatin-induced acute kidney injury.Regulation of taurine transport systems by protein kinase CK2 in mammalian cells.Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update.The role of taurine in renal disorders.Ion channels and transporters in the development of drug resistance in cancer cellsPhysiological role of taurine--from organism to organelle.Role of volume-regulated and calcium-activated anion channels in cell volume homeostasis, cancer and drug resistanceIn vitro characterization of a novel C,N-cyclometalated benzimidazole Ru(II) arene complex: stability, intracellular distribution and binding, effects on organic osmolyte homeostasis and induction of apoptosis.Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate.Beneficial Effects of Myo-Inositol Oxygenase Deficiency in Cisplatin-Induced AKI.Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.Introductory address for John Howland Award recipient, Russell Chesney, M.D.
P2860
Q28387506-4FED6889-91BF-4ADE-98F0-AAC520A57CA6Q30425669-5C399AB9-9602-455D-9881-94332BBB7F5AQ33655696-62FFFE07-6519-4A3E-A71F-8DCE5E430327Q34073302-FE1B2724-CA54-4F61-89BF-E262F1CBA9D8Q34260039-97138CC2-416A-4059-AF54-0B75CF8D1D9FQ34364243-6CC26910-A391-47B4-BACA-BDCD99DFC9DDQ34364313-7AC63641-C91A-4CAA-8B4F-DC0AB3B5729FQ35023913-2E5D68C8-9056-4254-8E18-CB86B0FC3AADQ35514172-58C439F6-8E38-4732-B987-17FB21A9B0D0Q37624605-85DC38D8-2D9F-4D57-8904-6C96CA2D5DEDQ37678608-C77325F1-CC03-461C-B3A3-830BCD4FBCC8Q37969550-E935FBD9-525C-4C38-BC8E-C555231FF7EBQ37989844-C47E5195-3C56-45F3-93CF-F9305DECEF86Q38009667-5BDDCDB6-AB02-4C31-8C73-77FA7437AB43Q38184991-181AD1EE-B4FF-4DAD-AE05-63EF26514961Q38241705-9BE5A753-FFCF-474E-9217-5E12FC26839DQ38633779-C9C3E61F-6826-4BD9-B674-12456CB38B5FQ38895597-9C12D1AB-3C1A-48B5-B4E3-3341AD5581CCQ38953627-D384B360-1ED2-42AD-8BDB-DF84ABCDCAF2Q39147435-31DD92FB-B1A2-419F-A8F2-29352F27A704Q41715901-45A792F7-820A-4274-9597-66291D48D8C2Q48297286-9A91FEB2-B660-4270-B442-4FF6CD2A191D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional TauT protects against acute kidney injury.
@en
Functional TauT protects against acute kidney injury.
@nl
type
label
Functional TauT protects against acute kidney injury.
@en
Functional TauT protects against acute kidney injury.
@nl
prefLabel
Functional TauT protects against acute kidney injury.
@en
Functional TauT protects against acute kidney injury.
@nl
P2093
P2860
P356
P1476
Functional TauT protects against acute kidney injury.
@en
P2093
Junming Yue
Russell W Chesney
Xiaobin Han
P2860
P304
P356
10.1681/ASN.2008050465
P577
2009-05-07T00:00:00Z